
Targacept and Catalyst Biosciences have signed a merger agreement which will see them develop new treatment options for patients with …
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics

